VANCOUVER, British Columbia, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading end-to-end drug researcher and formulator licensed by Health Canada, ...
The DEA has forwarded a petition to change the federal regulatory classification for psilocybin, the psychedelic compound found in "magic mushrooms," to HHS for a medical and scientific review. The ...
Toronto, Ontario--(Newsfile Corp. - June 7, 2024) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland"), a company engaged in the production, growth, and sale of ...
As many states and municipalities around the country grapple with the ever-increasing popularity of psilocybin-based products, a few have staked out leading positions in what may be the next wave of ...
The approval to initiate this Phase 2 clinical trial represents a pivotal moment in the clinical development of Optimi's GMP natural psilocybin extract capsules. Building on its established status as ...
Colorado could limit the state’s emerging magic mushroom industry to one strain and severely restrict the use of psilocybin extractions, according to the final draft of proposed natural medicine ...
Amid a renaissance in the science of psychedelics, public interest in psilocybin – or magic mushrooms, as they’ve long been ...
Nearly one in four Americans now believe that the use of psilocybin or “magic” mushrooms should be legal — a level of backing comparable to cannabis in the mid-1990s ahead of the introduction of ...
“We are in the middle of a rapidly evolving cultural, media, and legal landscape when it comes to psychedelics,” says Nora D. Volkow, M.D., director of the National Institute on Drug Abuse (NIDA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results